Table I.
Sociodemographic and Clinical Characteristics of the Sample (N = 389 Dyads)
| M/n | SD/% | |
| Parents | ||
| Age, M SD | 42.31 | 6.60 |
| Sex, n% | ||
| Male | 57 | 14.70 |
| Female | 332 | 85.30 |
| Marital status, n% | ||
| Single/separated/divorced/widowed | 60 | 15.42 |
| Married/partnered | 329 | 84.58 |
| SES, n% | ||
| Low | 213 | 54.80 |
| Medium | 139 | 35.70 |
| High | 37 | 9.50 |
| Children | ||
| Age-group, n% | ||
| Children (8–12 years) | 165 | 42.40 |
| Adolescents (13–20 years) | 224 | 57.60 |
| Sex, n% | ||
| Male | 208 | 53.50 |
| Female | 181 | 46.50 |
| Treatment status, n% | ||
| On-treatment | 190 | 48.80 |
| Off-treatment | 199 | 51.20 |
| Time since diagnosis in months, M SD | 28.15 | 27.02 |
| Relapse status, n% | ||
| Nonrelapse | 340 | 87.40 |
| Relapse | 49 | 12.60 |
| Malignancy, n% | ||
| Leukemias | 141 | 36.25 |
| Lymphomas | 97 | 24.94 |
| Langerhans cell histiocytosis | 9 | 2.31 |
| Solid tumor (extra central nervous system) | 104 | 26.74 |
| Central nervous system tumor | 38 | 9.77 |
| Intensity of treatment, n% | ||
| Least intensive | 12 | 3.10 |
| Moderately intensive | 141 | 36.20 |
| Very intensive | 173 | 44.50 |
| Most intensive | 63 | 16.20 |
Note. M = mean; SD = standard deviation.